Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_provenance.
- NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_assertion description "[Our previous study demonstrated that the TLR9 agonist CpG ODNs could significantly enhance the progression of human lung cancer cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_provenance.
- NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_assertion evidence source_evidence_literature NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_provenance.
- NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_assertion SIO_000772 19854217 NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_provenance.
- NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_assertion wasDerivedFrom befree-2016 NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_provenance.
- NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_assertion wasGeneratedBy ECO_0000203 NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_provenance.
- befree-2016 importedOn "2016-02-19" NP771455.RA_s9ZqybE9_OqNWIjJlSmD1Owl2pZVzJFlwY9RIAzKtI130_provenance.